A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Fecha
2020-06-08Autor
Wilk, Aaron J.
Rustagi, Arjun
Zhao, Nancy Q.
Roque, Jonasel
Martínez-Colón, Giovanny J.
McKechnie, Julia L.
Ivison, Geoffrey T.
Ranganath, Thanmayi
Vergara, Rosemary
Hollis, Taylor
Simpson, Laura J.
Grant, Philip
Subramanian, Aruna
Rogers, Angela J.
Blish, Catherine A.
Documentos PDF
Resumen en idioma extranjero
There is an urgent need to better understand the pathophysiology of Coronavirus disease 2019 (COVID-19), the global pandemic caused by SARS-CoV-2, which has infected more than three million people worldwide1. Approximately 20% of patients with COVID-19 develop severe disease and 5% of patients require intensive care2. Severe disease has been associated with changes in peripheral immune activity, including increased levels of pro-inflammatory cytokines3,4 that may be produced by a subset of inflammatory monocytes5,6, lymphopenia7,8 and T cell exhaustion9,10. To elucidate pathways in peripheral immune cells that might lead to immunopathology or protective immunity in severe COVID-19, we applied single-cell RNA sequencing (scRNA-seq) to profile peripheral blood mononuclear cells (PBMCs) from seven patients hospitalized for COVID-19, four of whom had acute respiratory distress syndrome, and six healthy controls. We identify reconfiguration of peripheral immune cell phenotype in COVID-19, including a heterogeneous interferon-stimulated gene signature, HLA class II downregulation and a developing neutrophil population that appears closely related to plasmablasts appearing in patients with acute respiratory failure requiring mechanical ventilation. Importantly, we found that peripheral monocytes and lymphocytes do not express substantial amounts of pro-inflammatory cytokines. Collectively, we provide a cell atlas of the peripheral immune response to severe COVID-19.
Palabras clave
COVID-19Enlace al recurso
https://www.nature.com/articles/s41591-020-0944-yColecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.